Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| CAL-85-1 | Ulixertinib | 3.16227766 | 0.4353 | 0.06077 |
| CAL-85-1 | Ulixertinib | 10.0 | 0.2848 | 0.05255 |
| CAL-85-1 | Ulixertinib | 10.0 | 0.2796 | 0.05302 |
| CAL-85-1 | Ulixertinib | 10.0 | 0.2311 | 0.05152 |
| CAL-85-1 | Alvocidib | 0.0001 | 1.1300 | -0.00387 |
| CAL-85-1 | Alvocidib | 0.0001 | 1.0270 | -0.00865 |
| CAL-85-1 | Alvocidib | 0.0001 | 0.5168 | 0.01097 |
| CAL-85-1 | Alvocidib | 0.000316227766017 | 1.0914 | 0.00071 |
| CAL-85-1 | Alvocidib | 0.000316227766017 | 0.9903 | -0.00134 |
| CAL-85-1 | Alvocidib | 0.000316227766017 | 0.9945 | -0.00701 |
| CAL-85-1 | Alvocidib | 0.001 | 1.0439 | -0.00374 |
| CAL-85-1 | Alvocidib | 0.001 | 0.9033 | 0.00425 |
| CAL-85-1 | Alvocidib | 0.001 | 0.8804 | 0.01181 |
| CAL-85-1 | Alvocidib | 0.00316227766017 | 0.7975 | 0.00288 |
| CAL-85-1 | Alvocidib | 0.00316227766017 | 1.1046 | -0.00606 |
| CAL-85-1 | Alvocidib | 0.00316227766017 | 0.7356 | 0.00168 |
| CAL-85-1 | Alvocidib | 0.01 | 0.7758 | 0.00153 |
| CAL-85-1 | Alvocidib | 0.01 | 1.0089 | -0.00751 |
| CAL-85-1 | Alvocidib | 0.01 | 0.0873 | 0.04987 |
| CAL-85-1 | Alvocidib | 0.0316227766017 | 0.9864 | -0.01038 |
| CAL-85-1 | Alvocidib | 0.0316227766017 | 1.0710 | 0.00137 |
| CAL-85-1 | Alvocidib | 0.0316227766017 | 0.4056 | 0.00782 |
| CAL-85-1 | Alvocidib | 0.1 | 0.8466 | 0.00491 |
| CAL-85-1 | Alvocidib | 0.1 | 0.8054 | 0.00522 |
| CAL-85-1 | Alvocidib | 0.1 | 0.8162 | 0.00174 |